Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

VITTLINK: A multi-centre international database study evaluating the association of vaccine-induced thrombosis and thrombocytopenia (VITT) with COVID-19 vaccination

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R22/232
  • Start year: 2022

Risk of Guillain-Barré syndrome (GBS) after COVID-19 vaccination and SARS-CoV-2 infection: A self-controlled risk interval study

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R22/231
  • Start year: 2022

VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00138-23
  • Start year: 2023
  • Funders: Research Triangle Institute (RTI)

A framework for the post-authorisation safety monitoring and evaluation of vaccines in the EU

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00020-24
  • Start year: 2024
  • Funders: Universiteit Utrecht

Post-Authorisation Safety Study of Comirnaty Original/Omicron BA.1 and Comirnaty Original/Omicron BA.4-5 in Europe

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00063-24
  • Start year: 2024